- Home
- NCSM vs BRNS Comparison
NCSM vs BRNS Comparison
Compare NCSM & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- BRNS
- Stock Information
- Founded
- NCSM 2006
- BRNS 2016
- Country
- NCSM United States
- BRNS United Kingdom
- Employees
- NCSM N/A
- BRNS N/A
- Industry
- NCSM Oilfield Services/Equipment
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- NCSM Energy
- BRNS Health Care
- Exchange
- NCSM Nasdaq
- BRNS Nasdaq
- Market Cap
- NCSM 79.3M
- BRNS 40.0M
- IPO Year
- NCSM 2017
- BRNS 2021
- Fundamental
- Price
- NCSM $29.45
- BRNS $0.90
- Analyst Decision
- NCSM
- BRNS Strong Buy
- Analyst Count
- NCSM 0
- BRNS 1
- Target Price
- NCSM N/A
- BRNS $3.00
- AVG Volume (30 Days)
- NCSM 9.0K
- BRNS 10.9K
- Earning Date
- NCSM 07-30-2025
- BRNS 08-07-2025
- Dividend Yield
- NCSM N/A
- BRNS N/A
- EPS Growth
- NCSM N/A
- BRNS N/A
- EPS
- NCSM 3.27
- BRNS N/A
- Revenue
- NCSM $168,704,000.00
- BRNS $14,969,000.00
- Revenue This Year
- NCSM $7.17
- BRNS N/A
- Revenue Next Year
- NCSM $5.44
- BRNS N/A
- P/E Ratio
- NCSM $9.04
- BRNS N/A
- Revenue Growth
- NCSM 18.16
- BRNS 4381.74
- 52 Week Low
- NCSM $15.90
- BRNS $0.64
- 52 Week High
- NCSM $38.95
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- NCSM 39.92
- BRNS 48.03
- Support Level
- NCSM $28.77
- BRNS $0.83
- Resistance Level
- NCSM $33.88
- BRNS $0.94
- Average True Range (ATR)
- NCSM 1.08
- BRNS 0.05
- MACD
- NCSM -0.22
- BRNS -0.00
- Stochastic Oscillator
- NCSM 4.58
- BRNS 34.88
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.